Neogen Corporation Operating Lease, Payments
Neogen Corporation (NEOG) reported Operating Lease, Payments of $6.50 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-07-30
- Neogen Corporation operating lease, payments for the quarter ending 2021-05-31 was $451.00K, a 45.48% increase year-over-year.
- Neogen Corporation operating lease, payments for the quarter ending 2021-02-28 was $303.00K, a 2.26% decline year-over-year.
- Neogen Corporation operating lease, payments for the quarter ending 2020-05-31 was $310.00K.
- Neogen Corporation operating lease, payments for the quarter ending 2020-02-29 was $310.00K.
- Neogen Corporation operating lease, payments for fiscal 2026 was $6.50M, a 14.04% increase from fiscal 2025.
- Neogen Corporation operating lease, payments for fiscal 2025 was $5.70M, a 21.28% increase from fiscal 2024.
- Neogen Corporation operating lease, payments for fiscal 2024 was $4.70M, a 119.73% increase from fiscal 2023.
- Neogen Corporation operating lease, payments for fiscal 2023 was $2.14M, a 52.03% increase from fiscal 2022.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $6.50M 10-K · filed 2026-07-30 | ||||
| 2025-05-31 | $5.70M 10-K · filed 2026-07-30 | $5.68M 10-K · filed 2025-07-30 | |||
| 2024-05-31 | $4.70M 10-K · filed 2026-07-30 | $4.71M 10-K · filed 2024-07-30 | |||
| 2023-05-31 | $2.14M 10-K · filed 2025-07-30 | ||||
| 2022-05-31 | $1.41M 10-K · filed 2024-07-30 | ||||
| 2021-05-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $754.00K derived: sum of 2 quarters · filed 2023-08-15 | $1.40M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | $303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $946.00K 10-Q · filed 2021-03-31 | |||
| 2020-11-30 | $643.00K 10-Q · filed 2020-12-29 | ||||
| 2020-05-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $620.00K derived: sum of 2 quarters · filed 2022-07-27 | $931.00K derived: sum of 3 quarters · filed 2022-07-27 | $1.18M 10-K · filed 2022-07-27 | |
| 2020-02-29 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $621.00K derived: sum of 2 quarters · filed 2021-03-31 | $868.00K 10-Q · filed 2021-03-31 | ||
| 2019-11-30 | $311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $558.00K 10-Q · filed 2020-12-29 | |||
| 2019-08-31 | $247.00K 10-Q · filed 2019-09-26 | ||||
| 2019-05-31 | $1.63M 10-K · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |